Literature DB >> 7554033

Assessing new anti-tumour agents and strategies in oncogene transgenic mice.

H Thomas1, F Balkwill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7554033     DOI： 10.1007/bf00665793

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


× No keyword cloud information.
  17 in total

Review 1.  Transgenic mice in cancer research.

Authors:  N A Jenkins; N G Copeland
Journal:  Important Adv Oncol       Date:  1989

2.  Pharmacologically guided phase I clinical trials based upon preclinical drug development.

Authors:  J M Collins; C K Grieshaber; B A Chabner
Journal:  J Natl Cancer Inst       Date:  1990-08-15       Impact factor: 13.506

3.  Impact of the genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas.

Authors:  H J Cho; M Seiberg; I Georgoff; A K Teresky; J R Marks; A J Levine
Journal:  J Neurosci Res       Date:  1989-09       Impact factor: 4.164

4.  Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene.

Authors:  L Bouchard; L Lamarre; P J Tremblay; P Jolicoeur
Journal:  Cell       Date:  1989-06-16       Impact factor: 41.582

Review 5.  Transgenic models of tumor development.

Authors:  J M Adams; S Cory
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

6.  Regulation of hepatic lipogenic enzyme gene expression by diet quantity in rats fed a fat-free, high carbohydrate diet.

Authors:  N Iritani; N Nishimoto; A Katsurada; H Fukuda
Journal:  J Nutr       Date:  1992-01       Impact factor: 4.798

7.  Chemotherapy of mammary carcinomas arising in ras transgenic mice.

Authors:  D L Dexter; M Diamond; J Creveling; S F Chen
Journal:  Invest New Drugs       Date:  1993 May-Aug       Impact factor: 3.850

8.  The use of animal models in cancer drug discovery and development.

Authors:  G A Curt
Journal:  Stem Cells       Date:  1994-01       Impact factor: 6.277

9.  Induction of a variety of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659----Glu659).

Authors:  Y Suda; S Aizawa; Y Furuta; T Yagi; Y Ikawa; K Saitoh; Y Yamada; K Toyoshima; T Yamamoto
Journal:  EMBO J       Date:  1990-01       Impact factor: 11.598

10.  An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues.

Authors:  J Hu; W Kindsvogel; S Busby; M C Bailey; Y Y Shi; P D Greenberg
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307
View more
  1 in total

1.  Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.

Authors:  Peter A Raven; Ninadh M D'Costa; Igor Moskalev; Zheng Tan; Sebastian Frees; Claudia Chavez-Munoz; Alan I So
Journal:  Am J Clin Exp Urol       Date:  2018-12-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.